CPC A61K 31/4178 (2013.01) [A61K 9/0048 (2013.01); A61K 31/14 (2013.01); A61K 31/498 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01)] | 22 Claims |
1. A pharmaceutically acceptable and ophthalmologically suitable gel composition for treating an ocular condition via administration to a mammalian eye, the composition comprising (1) a pilocarpine compound in an amount greater than 1% w/v; (2) a brimonidine compound in an amount of between 0.05% w/v and 0.2% w/v, and (3) at least one polyethoxylated castor oil, wherein the w/v ratio of the at least one polyethoxylated castor oil to the brimonidine compound is between about 1:0.06 and about 1:4.
|